Paper39150784
A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases.
Hou WC and 7 others. Proc Natl Acad Sci U S A, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases. Papers, record 39150784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39150784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Phosphatidylinositol 3-Kinases | Major topic |
| Lysosomes | Major topic |
| Glucosylceramidase | Major topic |
| Fibroblasts | Major topic |
| Lysosomal Storage Diseases | Major topic |
| Humans | |
| Gaucher Disease | |
| Phosphoinositide-3 Kinase Inhibitors |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| RF1 AG073418 | NIA NIH HHS | United States | R01AG073418 | PubMed and NIH | NIH RePORTER |
| AG073418 | HHS | NIH | National Institute on Aging (NIA) | R01AG073418 | PubMed and NIH | NIH RePORTER | |
| R01 AG073418 | NIA NIH HHS | United States | R01AG073418 | PubMed and NIH | NIH RePORTER |
| N/A | Rainwater Charitable Foundation (RCF) | PubMed | PubMed | ||
| N/A | JBP Foundation | PubMed | PubMed | ||
| RF1AG073418 | NIH | NIH RePORTER |
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19556463 | A gene network regulating lysosomal biogenesis and function. | Science | 2009 | https://conductscience.org/library/papers/19556463 | PubMed |
| 2 | 27023912 | Glycosylation is crucial for a proper catalytic site organization in human glucocerebrosidase. | Glycoconj J | 2016 | https://conductscience.org/library/papers/27023912 | PubMed |
| 3 | 12434014 | Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/12434014 | PubMed |
| 4 | 35760104 | Inhibition of lipid kinase PIKfyve reveals a role for phosphatase Inpp4b in the regulation of PI(3)P-mediated lysosome dynamics through VPS34 activity. | J Biol Chem | 2022 | https://conductscience.org/library/papers/35760104 | PubMed |
| 5 | 31628917 | Small molecule PIKfyve inhibitors as cancer therapeutics: Translational promises and limitations. | Toxicol Appl Pharmacol | 2019 | https://conductscience.org/library/papers/31628917 | PubMed |
| 6 | 16192271 | HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. | J Biol Chem | 2005 | https://conductscience.org/library/papers/16192271 | PubMed |
| 7 | 23544129 | Inhibition of PIKfyve by YM-201636 dysregulates autophagy and leads to apoptosis-independent neuronal cell death. | PLoS One | 2013 | https://conductscience.org/library/papers/23544129 | PubMed |
| 8 | 15711537 | A small molecule-kinase interaction map for clinical kinase inhibitors. | Nat Biotechnol | 2005 | https://conductscience.org/library/papers/15711537 | PubMed |
| 9 | 27438886 | PIKfyve inhibition increases exosome release and induces secretory autophagy. | Cell Mol Life Sci | 2016 | https://conductscience.org/library/papers/27438886 | PubMed |
| 10 | 25126989 | ERdj3 is an endoplasmic reticulum degradation factor for mutant glucocerebrosidase variants linked to Gaucher's disease. | Chem Biol | 2014 | https://conductscience.org/library/papers/25126989 | PubMed |
| 11 | 32743826 | Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease. | J Neurochem | 2021 | https://conductscience.org/library/papers/32743826 | PubMed |
| 12 | 26392287 | Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons. | Neurobiol Dis | 2015 | https://conductscience.org/library/papers/26392287 | PubMed |
| 13 | 11123925 | PIKfyve lipid kinase is a protein kinase: downregulation of 5'-phosphoinositide product formation by autophosphorylation. | Biochemistry | 2000 | https://conductscience.org/library/papers/11123925 | PubMed |
| 14 | 19918967 | Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease. | Inflamm Bowel Dis | 2010 | https://conductscience.org/library/papers/19918967 | PubMed |
| 15 | 23890009 | PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling. | Chem Biol | 2013 | https://conductscience.org/library/papers/23890009 | PubMed |
| 16 | 39150784 | A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39150784 | PubMed |
| 17 | 34738088 | Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate Cancer. | Nat Cancer | 2021 | https://conductscience.org/library/papers/34738088 | PubMed |
| 18 | 17163678 | Chemical chaperones and permissive temperatures alter localization of Gaucher disease associated glucocerebrosidase variants. | ACS Chem Biol | 2006 | https://conductscience.org/library/papers/17163678 | PubMed |
| 19 | 18351385 | Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients. | Virchows Arch | 2008 | https://conductscience.org/library/papers/18351385 | PubMed |
| 20 | 26354342 | Clinical Improvement of Alpha-mannosidosis Cat Following a Single Cisterna Magna Infusion of AAV1. | Mol Ther | 2016 | https://conductscience.org/library/papers/26354342 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42681571 | Targeting PIKfyve: Chemical Biology and Drug Discovery Insights. | Chem Biol Drug Des | 2026 | https://conductscience.org/library/papers/42681571 | PubMed |
| 42657790 | Disruption of sphingolipid metabolism promotes tau seeding through endolysosomal membrane rigidification and rupture. | Elife | 2026 | https://conductscience.org/library/papers/42657790 | PubMed |
| 42439703 | Reducing PI4KIIIα Levels or Activity Limits Tau Seed Internalization and Assembly in Human Cortical Neurons. | Cells | 2026 | https://conductscience.org/library/papers/42439703 | PubMed |
| 41459692 | The Race to Salvage Glucocerebrosidase: Understanding Small-Molecule Therapies for GBA1-Associated Parkinsonism. | Mov Disord | 2026 | https://conductscience.org/library/papers/41459692 | PubMed |
| 41301891 | GBA1 Gene-Associated Transcriptomic Signatures Reveal Risk Genes in Parkinson's Disease. | Biomedicines | 2025 | https://conductscience.org/library/papers/41301891 | PubMed |
| 40138089 | Integrative analysis based on CRISPR screen identifies apilimod as a potential therapeutic agent for cisplatin-induced acute kidney injury treatment. | Sci China Life Sci | 2025 | https://conductscience.org/library/papers/40138089 | PubMed |
| 39150784 | A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39150784 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PIKFYVE | 200576 | PubTator's text mining | https://conductscience.org/library/genes/200576 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39150784
GET https://conductscience.org/api/papers/v1/39150784/references?page=2